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ABSTRACT
E
xperiments with insects, protozoa, nematodes, and
slime molds have recently come to the forefront in the
study of host–fungal interactions. Many of the
virulence factors required for pathogenicity in mammals are
also important for fungal survival during interactions with
non-vertebrate hosts, suggesting that fungal virulence may
have evolved, and been maintained, as a countermeasure to
environmental predation by amoebae and nematodes and
other small non-vertebrates that feed on microorganisms.
Host innate immune responses are also broadly conserved
across many phyla. The study of the interaction between
invertebrate model hosts and pathogenic fungi therefore
provides insights into the mechanisms underlying pathogen
virulence and host immunity, and complements the use of
mammalian models by enabling whole-animal high
throughput infection assays. This review aims to assist
researchers in identifying appropriate invertebrate systems
for the study of particular aspects of fungal pathogenesis.
Introduction
Most studies of bacterial or fungal infectious diseases focus
separately on the pathogenic microbe, the host response, or
the characterization of therapeutic compounds.
Compartmentalization of pathogenesis-related research into
an analysis of the ‘‘pathogen’’, the ‘‘host,’’ or the
‘‘antimicrobial compound’’ has largely been dictated by the
lack of model systems in which all of these approaches can be
used simultaneously, and by the traditional view that
microbiology, immunology, and chemical biology and
pharmacology are separate disciplines. The arbitrary
separation of these ﬁelds is no longer necessary, as genetic
and genomic tools for a number of pathogenic microbes are
now available and an extensive understanding of virulence
mechanisms and host responses has been achieved. We see
the traditional separation of these disciplines as a major
hindrance to the development of novel antimicrobial agents
and groundbreaking therapies. For example, we think that
there are a number of shortcomings with the currently
accepted ‘‘gold standard’’ approach of using an in vitro assay
to determine the minimal inhibitory concentration of
compounds against a pathogen of interest. Measuring
minimal inhibitory concentrations does not allow the
simultaneous evaluation of toxicity or the identiﬁcation of
compounds that have an immunomodulatory effect that
augments the host response to the infection or those that
have a dual effect (a direct antimicrobial effect as well as an
immunomodulatory effect).
A number of different invertebrate host model systems
have been described in the past few years (Box 1) that allow
multidisciplinary studies of host–fungal interactions from the
perspectives of both the pathogen and the host. A variety of
fungi involved in mammalian pathogenesis can infect and kill
non-vertebrate model hosts. Consequently, many researchers
have turned to non-vertebrates as facile, ethically expedient,
relatively simple, and inexpensive hosts to model a variety of
human infectious diseases. An important advantage of many
non-vertebrate hosts is that they are small enough to ﬁt in
microtiter plates, which makes it possible to use them in high
throughput studies designed to scan pathogen genomes for
virulence-related genes or to scan chemical libraries for
antimicrobial compounds. Moreover, because many non-
vertebrate hosts are genetically tractable, they can be used in
conjunction with an appropriate pathogen to study host
innate immunity. As it has become apparent that it is
important to select the model host that is best suited to test a
speciﬁc hypothesis (Table 1), this review is designed to help
investigators in the ﬁeld of fungal pathogenesis address some
important questions as they navigate through the advantages
and disadvantages of different non-vertebrate models.
What Is the Virulence Trait under Study?
A recurrent ﬁnding in recent studies of fungal virulence
factors is that many of the same pathogenesis traits are
required for virulence in both mammals and non-vertebrate
hosts. For example, in the pathogenic yeast Cryptococcus
neoformans, genes associated with the GPA1, PKA1, PKR1, and
RAS1 signal transduction pathways, which regulate important
Editor: B. Brett Finlay, University of British Columbia, Canada
Citation: Mylonakis E, Casadevall A, Ausubel FM (2007) Exploiting amoeboid and
non-vertebrate animal model systems to study the virulence of human pathogenic
fungi. PLoS Pathog 3(7): e101. doi:10.1371/journal.ppat.0030101
Copyright:  2007 Mylonakis et al. This is an open-access article distributed under
the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author
and source are credited.
Abbreviations: GNBP, Gram-negative binding protein; TIR, Toll–interleukin 1
receptor; TLR, Toll-like receptor
Eleftherios Mylonakis is with the Division of Infectious Diseases, Massachusetts
General Hospital, Boston, Massachusetts, United States of America. Arturo
Casadevall is with the Albert Einstein College of Medicine, Bronx, New York, United
States of America. Frederick M. Ausubel is with the Department of Molecular
Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of
America, and the Department of Genetics, Harvard Medical School, Boston,
Massachusetts, United States of America.
* To whom correspondence should be addressed. E-mail: ausubel@molbio.mgh.
harvard.edu
PLoS Pathogens | www.plospathogens.org July 2007 | Volume 3 | Issue 7 | e101 0859virulence factors in mammalian pathogenesis, have also been
shown to play a role in the killing of the nematode
Caenorhabditis elegans and the insects Drosophila melanogaster
and Galleria mellonella [1–3]. The extent of the similarities
between fungal virulence factors required in mammalian and
non-vertebrate hosts is illustrated by studies of the C.
neoformans mating locus. More speciﬁcally, the role of the C.
neoformans mating locus in invertebrates is similar to that in
mice [4–6]. The MFa1 gene, which regulates production of the
mating type MFa pheromone and is associated with increased
virulence in mammalian models [5], is involved in the killing
of nematodes [2] and insects [3] by C. neoformans var.
neoformans, but not by C. neoformans var. grubii [3,4].
The similarities between simple model hosts and mammals
extend in some cases to the intracellular fate of fungi. C.
neoformans replicates inside macrophages as well as within the
amoeba Acanthamoeba castellani, and in both cases, the ingested
C. neoformans synthesize capsular polysaccharides that are
required for virulence [7–11]. It is noteworthy that
stimulation of A. castellani with arachidonic acid and
prostaglandins enhances the phagocytic efﬁcacy of the
amoeboid cells [12], an observation that is relevant to
amoeba–fungal interactions given that many fungal species
produce these compounds [13,14]. However, further study is
needed, as the intracellular fate of cryptococci in insect
hemocytes is not known.
An exciting hypothesis based on the conservation of fungal
virulence factors for diverse hosts is that fungal signaling
cascades and associated virulence factors that confer a
survival advantage during the infection of mammalian hosts
originally evolved during the interaction of fungi with
environmental predators [15], including insects such as D.
melanogaster, that primarily consume plant saprophytic or
pathogenic fungi. Similarly, many bacterial virulence factors,
especially in opportunistic environmental pathogens such as
Pseudomonas aeruginosa, are involved in both mammalian
pathogenesis and predation avoidance by nematodes and
amoebae [16–18].
The phenomenon of fungal dimorphism, an important
aspect of fungal virulence in mammals, may also have
emerged as a mechanism for escaping predators. For
example, Histoplasma capsulatum transitions to a hyphal form
when exposed to A. castellani amoebae [19] and Candida
albicans ﬁlaments upon ingestion by C. elegans [20]. These
ﬁndings complement an earlier observation that C. neoformans
hyphal forms survive predation by Acanthamoebae polyphaga,
whereas yeast forms are consumed [8]. In vitro, these
transitions to hyphal forms only occur at 37 8C, but they can
occur at ambient temperatures in the presence of the
invertebrate hosts. Given that there are many thousands of
species that are microherbivores, it is likely that the ability of
fungi to interconvert between yeast and hyphal forms
provides protection against particular predators.
In addition to the potential evolutionary origins of fungal
virulence, interactions between fungi and invertebrate hosts
may play an important role in the maintenance of virulence
in mammalian hosts. For example, passage of an avirulent H.
capsulatum strain in amoeba is associated with an increase in
virulence for mice [19]. Also, the C. neoformans Ras signaling
cascade is required for cryptococcal virulence because it
regulates growth at high temperature (37 8C) [21]. However,
RAS1 plays a signiﬁcant role in C. elegans ([2] and E. Mylonakis,
unpublished data), Drosophila [1], and G. mellonella [3]
pathogenesis at 20 8C, 25 8C, and 30 8C, respectively.
Importantly, there is a signiﬁcant amount of host
speciﬁcity between fungal pathogens and non-vertebrate
hosts that needs to be taken into account when selecting an
invertebrate system. For example, the dimorphic fungi
Blastomyces dermatidis, Sporothrix schenckii, and H. capsulatum, as
well as the basidiomycetous fungus C. neoformans, kill A.
castellanii and grow in the presence of the amoebae, whereas
A. castellani readily kills C. albicans [19]. Also, the experimental
conditions must be considered, as they should be conducive
to the virulence factor under study. For example, C. albicans
ﬁlamentation is only induced within C. elegans when the
nematode is in liquid medium [20] (Figure 1).
Interestingly, in many cases, non-vertebrate hosts allow
comparative studies of fungal pathogenesis. For example, C.
neoformans and C. albicans, which have very different ecological
niches, kill C. elegans nematodes by implementing signiﬁcantly
different pathogenic processes. The mechanism by which
cryptococcal cells kill C. elegans is not clear. They do not
adhere to the nematode intestine, and nematodes exposed to
cryptococcal lawns are able to defecate the cryptococcal cells
upon transfer to liquid medium, thereby clearing the
cryptococcal infection [2,20]. In contrast, Candida species
establish persistent infections of the C. elegans intestine,
dissolve nematode tissues, and break through the nematode
cuticle by forming an impressive network of ﬁlaments [20]
(Figure 2).
Another important point is that even when a fungal species
is virulent in several hosts, different virulence traits are not
Box 1.
Methodology Used to Study Fungal Pathogenesis in
Representative Invertebrate Model Hosts
Drosophila:
  Injection: pricking the fly thorax, or abdomen, with a needle that has
been dipped in a suspension of the microbe. If administration of
exact inocula is necessary, microinjection of a precise dose of
microbes directly into the body cavity is available.
  ‘‘Natural infection’’
i. Feeding Drosophila larvae or adults with a concentrated
solution that has been mixed with their food,
ii. spraying fungal spores directly onto the fly exoskeleton, or,
iii. ‘‘rolling’’ flies on agar plates that have been spread with the
pathogen (‘‘rolling assay’’).
Acanthamoeba:
  Co-incubation of amoebae and C. neoformans leads to phagocytosis,
amoebae killing, or fungal cell killing, depending on the species of
amoebae or cryptococcal strain.
C. elegans:
  Killing assays involve transferring C. elegans animals (usually at the L4
developmental stage) from a lawn of Escherichia coli strain OP50 to a
lawn of the pathogen.
D. discoideum:
  Co-incubation of amoeboid cells of D. discoideum and C. neoformans
leads to phagocytosis, although the process is less efficient than it is
with amoebae, possibly because of the smaller size of the host cell.
G. mellonella:
  A syringe is used to inject aliquots of the inoculum into the
hemocoel of G. mellonella caterpillars in the final instar larval stage
via a larva proleg.
PLoS Pathogens | www.plospathogens.org July 2007 | Volume 3 | Issue 7 | e101 0860necessarily equally important in the different systems. For
example, the cryptococcal polysaccharide capsule that is
essential for mammalian infection also enables cryptococci to
survive phagocytosis by A. castellanii [11] or Dictyostelium
discoideum [15] and to kill the insect G. mellonella [3]. However,
acapsular C. neoformans strains are still able to kill C. elegans [2].
What Is the Desired Host Response?
In addition to the signiﬁcance of the virulence trait under
study, consideration should be given to the host response.
Host innate immune responses are broadly conserved across
many host phyla, and fungal virulence factors may target
signal transduction cascades that are shared between
mammals and non-vertebrate environmental predators.
Evolutionary conservation of innate mechanisms of host
defense is exempliﬁed by the conservation of the Toll-like
signaling pathways in mammals and insects. Since Lemaitre et
al. demonstrated that the Toll receptor, previously known for
its essential role during Drosophila embryonic development, is
required for antifungal defense in Drosophila, and that
mutations in the Toll signaling pathway dramatically reduced
survival after Aspergillus fumigatus infection [22], Drosophila has
emerged as a preferred animal host in which to study the
genetic control of immune recognition and response.
Drosophila provides genetic tractability and a variety of
genomic tools, including full-genome microarrays [23,24] and
RNA interference libraries [25,26], that can be utilized to
identify immune-related genes. An advantage of Drosophila is
that both systemic and local inoculations can be performed
(Box 1), because the infection can be achieved by systemic
injection as well as by local infection, such as feeding.
However, it should be noted that the mechanical
manipulation associated with systemic inoculation in
Drosophila might affect the humoral [27–29] and cellular [30]
responses, and this should be taken into account when
evaluating the response of Drosophila to fungi, since such a
response may be due to the trauma of the inoculation and not
the fungal infection.
Genetic screens in Drosophila used to isolate mutants unable
to induce humoral responses to infection led to the
identiﬁcation of components of two parallel signaling
cascades, the Toll and Imd pathways [31], both of which
contribute to the Drosophila defense response against
microbes [32,33]. Although there appear to be some
exceptions, the Toll pathway is primarily activated by fungal
and Gram-positive bacterial pathogens, whereas the Imd
pathway is primarily activated by Gram-negative bacteria. A
major area of focus has been the identiﬁcation of the
pathogen recognition receptors that function in these two
Drosophila immune pathways. This effort led to the discovery
of families of peptidoglycan binding proteins and Gram-
negative binding proteins (GNBPs) [34–37]. Recently
published work shows that the GNBP family of pathogen
recognition proteins, in particular GNBP3, is also required
for the activation of the Toll pathway in response to fungal
pathogens [37].
In contrast to Drosophila, mammals have at least ten
members of the Toll-like receptor (TLR) family that
participate in pathogen recognition [38,39]. TLRs are
transmembrane proteins that consist of an extracellular
leucine-rich repeat domain and an intracellular Toll–
interleukin 1 receptor (TIR) domain. In both Drosophila and
mammals, a key signaling component downstream of TLRs is
the TIR domain that contains protein MyD88, which in
mammals is essential for inﬂammatory cytokine production
through all TLRs. In mammals, as in Drosophila, TLRs and
MyD88 have been implicated in the pathway involved in
recognition of fungal pathogens, including A. fumigatus [39–
41], C. albicans [41,42], Coccidioides posadasi [43], C. neoformans
[44,45], and Pneumocystis [46]. The role of individual receptors
such as TLR2, TLR4, and TLR9 in MyD88 activation varies
depending on the fungus and the site of infection [38].
The similarities between insect and human responses to
pathogenic fungi are not limited to D. melanogaster. For
example, the host response of the greater wax moth, G.
mellonella, includes six types of hemocytes, phagocytosis, and
‘‘nodulation’’ (encapsulation of large invading pathogens by
layers of hemocytes) (reviewed in [47]). Hemocytes of G.
mellonella are capable of phagocytosing fungal cells of C.
albicans [48], C. neoformans [3], and Aspergillus spp. [49,50], and
the kinetics of phagocytosis and microbial killing are similar
to those of human neutrophils [48]. Interestingly,
immunoblotting of G. mellonella hemocytes with antibodies
raised against human neutrophil phox proteins revealed the
presence of proteins homologous to p67phox and p47phox
[48] that, in humans, has been associated with chronic
granulomatous disease [51].
Table 1. Comparison of Representative Invertabrate Model Hosts That Have Been Used for the Study of Fungal Pathogenesis
Experimental Features A. castellanii C. elegans D. discoideum D. melanogaster G. mellonella
Precise inocula þ   þ þþ þþþ
Ability to evaluate antifungal agents ? þþþ ? þþ þ
Forward and reverse genetics or
mutant strains available
þ þþþ þþþ þ þ
Microarrays   þþþ þ þþþ  
Overall cost þþþ þþþ þþþ þþ þþþ
RNA interference libraries   þþþ þ þþþ  
Sequenced genome   þþþ þþþ þþþ  
Short reproductive cycle þþþ þþþ þþþ þþ N/A (larvae are usually obtained from vendor)
Survive at 37 8C þ  -  þ þ
The more þ, the stronger the model is for the particular indication.
doi:10.1371/journal.ppat.0030101.t001
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and mammals, the complete pathway does not appear to be
required for an effective immune response in all non-
vertebrates. C. elegans, for example, has structural homologs of
some Toll pathway components, including tol-1, trf-1, pik-1,
and ikb-1, which are homologs of mammalian TLRs, TRAF6,
IRAK, and IkB, respectively, but is missing homologs of
MyD88 and NF-jB [52]. On the other hand, C. elegans does
have a TIR domain protein, referred to as TIR-1, that is a
homolog of the human SARM protein [53,54]. In C. elegans,
however, TIR-1 functions as a positive regulator of the
antimicrobial peptide NLP-31, a member of the
neuropeptide-like protein family. Puriﬁed NLP-31 has
antifungal activity towards Drechmeria coniospora, Neurospora
crassa, and A. fumigatus, and C. elegans is more susceptible to D.
coniospora when tir-1 is silenced via RNA interference [54]. As
in Drosophila, genetic screens have also been carried out to
identify components of a presumptive C. elegans innate
immune response pathway upstream of induced defense
responses. A forward genetic screen demonstrated a
requirement for a conserved p38 mitogen-activated protein
kinase pathway in C. elegans immunity [55] that functions
downstream of TIR-1 [53,56].
It is reasonable to expect that interaction of pathogens
with evolutionarily distant hosts will continue to provide
useful insights into the study of the evolution of immune
signaling and to enhance our understanding of evolution in
general. For example, studying the commonalities in innate
immunity cascades sheds light on whether coelomates form a
single clade, the Coelomata, or whether all animals that molt
an exoskeleton (arthropods and nematodes) form a distinct
clade, the Ecdysozoa [57–59]. For example, the presence of
highly conserved Toll signaling pathways in Drosophila and
mammals and the lack of key Toll signaling components in C.
elegans may argue in favor of the Coelomata hypothesis [59].
What Is the Appropriate Endpoint of a
Pathogenicity Assay?
Many microbial virulence traits are induced only in the
host, and therefore the study of these traits may require
doi:10.1371/journal.ppat.0030101.g001
Figure 1. Dead C. elegans Nematodes Infected by C. albicans
Filamentation is instrumental for Candida virulence in mammals and is also involved in the killing of C. elegans [20]. The four panels show consequences
of infecting C. elegans glp-4;sek-1 animals with C. albicans and then moving them into pathogen-free liquid medium. The top panels show that C.
albicans cells persist within the C. elegans intestine and form hyphae (green) that break through the C. elegans cuticle, leaving a C. elegans ‘‘ghost’’ (dark
structure) that outlines where the cuticle used to be. The bottom panels show that Candida cells develop filaments (green) that differentiate into
hyphae, long continuous germ tubes separated by true septin rings, or pseudohyphae, chains of distinct cells that fail to separate. Pictures were taken
with a confocal laser microscope (TCS NT; Leica Microsystems, http://www.leica-microsystems.com/). Concanavalin A-Alexafluor (fluorescence emission
at 519 nm) is a fluorescent green dye that binds to polysaccharides. FUN-1, which was also used in the bottom right panel, is a fluorescent yellow dye
that is absorbed by metabolically active fungal cells and fluoresces red when illuminated with a fluorescence emission 480 nm [20].
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pathogenic microbes interact with human hosts are most
commonly studied using mammalian models of infection.
However, the study of pathogenesis in mammalian models is
complicated by difﬁculties of handling, long reproductive
cycles, small brood sizes, physiological and anatomical
complexity, regulatory requirements, high cost, and ethical
considerations. In particular, the use of invertebrate hosts in
genetic screens that involve a large number of host
individuals is especially appealing. In invertebrate model
hosts, the most common phenotype used to monitor the
progress of an infection is the death of the host. In one such
study, the killing of C. elegans by C. neoformans was used to
screen a library of random C. neoformans insertion mutants.
Approximately 2% of the mutants tested demonstrated
attenuated virulence in C. elegans, and these phenotypes were
veriﬁed by showing that they persisted after crossing the
relevant mutations back into a wild-type strain [60].
Mutated invertebrate hosts that express a convenient
reporter or are immunocompromised are particularly useful
when there is a need for an unambiguous endpoint. For
example, as noted above, injection of fungi into wild-type
Drosophila leads to an increase of antimicrobial peptides that
are very effective against fungi [22,33,61–63]. The increase in
antimicrobial peptides is not observed in Toll mutants of
Drosophila that are susceptible to systemic inoculation, and
researchers have demonstrated that Toll mutants are
susceptible to A. fumigatus [22], C. neoformans [1], or Candida
spp. [61] pathogenesis. In addition to facilitating
experiments, these studies also provide an interesting
example of microbial opportunism. In humans, invasive
fungal infections are most commonly associated with immune
deﬁciency of the host. This phenomenon of microbial
opportunism (the fact that low virulence microbes can cause
disease in hosts with impaired immunity) appears to have
counterparts at the unicellular level. For example, acapsular
C. neoformans are not able to grow in wild-type cells of the
slime mold D. discoideum, but D. discoideum mutants defective in
Myosin VII (which is involved in cell and particle adhesion
during phagocytosis) are susceptible to acapsular C.
neoformans [15].
Death of the host is not the only phenotype that has been
used to monitor pathogenesis in non-vertebrate hosts. C.
neoformans not only kills C. elegans, but also accumulates to
high levels in the C. elegans intestinal tract and prevents the
self-fertilizing hermaphrodites from producing a brood of
progeny. In contrast to C. neoformans, nonpathogenic
cryptococci such as Cryptococcus laurentii are unable to survive
ingestion by the nematode, and do not interfere with progeny
production. By screening a library of C. neoformans randomly
generated insertional mutants for strains that permitted the
production of C. elegans progeny, researchers have identiﬁed
mutants that had a progeny-permissive phenotype. These
mutants corresponded to genes involved in maintenance of
the cryptococcal cell wall, including a homolog of
Saccharomyces cerevisiae ROM2, which encodes a Rho1p
activator in the protein kinase C pathway that regulates cell
wall integrity [64]. Interestingly, C. neoformans rom2 was unable
to survive ingestion by the nematode and is avirulent in an
inhalation infection model in mice [64].
The use of invertebrates in automated, high throughput in
vivo assays can be viewed as an emerging technology related
to the use of invertebrate hosts. An example is a whole-animal
C. elegans assay that allows screening for low molecular weight
compounds with activity against C. albicans. C. albicans, as well
as other Candida spp., are ingested by C. elegans and establish a
persistent lethal infection in the C. elegans intestinal tract.
Importantly, key components of Candida pathogenesis in
mammals, such as bioﬁlm and ﬁlament formation, are also
involved in nematode killing [20]. A liquid assay for C. elegans–
C. albicans pathogenesis was developed using standard 96-well
or 384-well microtiter plates, which hold about 25 or 15
worms per well, respectively. A pilot screen of 1,266
compounds with known pharmaceutical activities identiﬁed
doi:10.1371/journal.ppat.0030101.g002
Figure 2. Wild-Type C. neoformans Accumulates in the Gastrointestinal Tract
Intact yeast cells are present in the distended (A) proximal and (B) distal gastrointestinal tract of C. elegans after feeding for 36 h on C. neoformans strain
KN99a. Black arrows point to the intestinal lumen. The white arrowheads note the pharyngeal grinder organ, which functions to disrupt ingested
organisms.
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nematodes and inhibited in vivo ﬁlamentation of C. albicans.
Three of the 15 compounds have been tested in mice, and two
out of three of these compounds, caffeic acid phenethyl ester,
a major active component of honeybee propolis, and the
ﬂuoroquinolone agent enoxacin, exhibited anti-fungal
activity in mice [20].
Selecting an Invertebrate Model System
No invertebrate model system reproduces all aspects of
mammalian infection, and any particular invertebrate is
likely to have speciﬁc advantages, including the fact that the
selected host may be found in the natural environment of the
fungal pathogen in question. The selection of a model system
for studying fungal virulence is largely dependent on the
speciﬁc pathogen virulence-related factors, the speciﬁc host
innate immune responses of interest, and the scientiﬁc
question asked. If the goal is to study innate immune
responses, the choice most likely will require the selection of
a multicellular model genetic organism such as Drosophila or
C. elegans. If the goal is to study phagocytosis and/or the
outcome of ingestion, the choices include unicellular
organisms such as amoebae and slime mold or invertebrates
such as insects with phagocytic cells. Similarly, if the goal is to
study fungal processes that are operative at mammalian
temperatures, then one must select a model system that is
thermotolerant, such as G. mellonella or amoebae, or the
emerging model Panagrellus redivivus that can be propagated
at 37 8C [65].
The identiﬁcation of processes that are reproduced in
more than one host may represent ancient mechanisms of
cell–cell interactions. Nevertheless, it is important to keep in
mind when choosing a model host that metazoans, protista,
and slime molds are separated by enormous evolutionary
distances and that many host-speciﬁc phenomena are likely
to exist. For example, recent work suggests that
internalization of C. neoformans cells by alveolar macrophages
increases the dissemination of C. neoformans to the central
nervous system [66], which would be difﬁcult to study in an
invertebrate model.
Conclusions
In summary, workers in the ﬁeld of fungal pathogenesis
have the opportunity to select from several invertebrate
animal model systems in their studies. An understanding of
the unique strengths and limitations associated with each
model host is necessary, as particular virulence traits are not
equally important in all systems and genetic tractability is not
available in all model hosts. Although these model systems are
currently available for studying fungal pathogenicity in non-
mammalian hosts, it is important to consider that they
represent a minute fraction of the potential hosts available.
Among the protista, for example, only a couple of amoebae
species have been studied in a kingdom that includes a large
number of species. Consequently, better model systems may
be identiﬁed in the future, and there is a need to continue to
explore fungal interactions with non-mammalian hosts.
Nevertheless, the systems currently available provide
investigators with many new options for studying fungal
virulence and pathogenicity. Selecting the model that best
addresses an experimental hypothesis is dependent on the
questions asked and the strengths and limitations of the
various systems. Invertebrate model systems have already
provided novel insights into the origins of fungal
pathogenicity, and one can conﬁdently expect that they will
continue to facilitate the study of the evolution and
maintenance of fungal virulence. &
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